Disetronic claims first with open access injector:
This article was originally published in Clinica
Disetronic Medical Systems has launched its Disetronic Pen injector, claiming it is the first insulin injector on the US market which allows patients to choose their own insulin manufacturer and to fill the pen using supplies of insulin in the more economical vial format. Other manufacturers' products use single-use disposable or custom pre-filled pens.
You may also be interested in...
Cilta-cel maintained high response rates in longer-term multiple myeloma data, but ide-cel causes less cytokine release syndrome and severe neurotoxicity – and it has a March decision date at the US FDA.
Our updated graphic tracker of key developments from the leading vaccine candidates.
Pathway open for drug as post-covalent BTK option as Loxo gears up for "risky" Phase III head-to-head study in Q1 2021.